Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma.
Pinnix CC, Smith GL, Milgrom S, Osborne EM, Reddy JP, Akhtari M, Reed V, Arzu I, Allen PK, Wogan CF, Fanale MA, Oki Y, Turturro F, Romaguera J, Fayad L, Fowler N, Westin J, Nastoupil L, Hagemeister FB, Rodriguez MA, Ahmed S, Nieto Y, Dabaja B. Pinnix CC, et al. Among authors: hagemeister fb. Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):175-82. doi: 10.1016/j.ijrobp.2015.02.010. Int J Radiat Oncol Biol Phys. 2015. PMID: 25863764 Free PMC article.
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.
Tsimberidou AM, McLaughlin P, Younes A, Rodriguez MA, Hagemeister FB, Sarris A, Romaguera J, Hess M, Smith TL, Yang Y, Ayala A, Preti A, Lee MS, Cabanillas F. Tsimberidou AM, et al. Among authors: hagemeister fb. Blood. 2002 Dec 15;100(13):4351-7. doi: 10.1182/blood-2001-12-0269. Epub 2002 Aug 8. Blood. 2002. PMID: 12393618 Free article. Clinical Trial.
Radiotherapy alone for lymphocyte-predominant Hodgkin's disease.
Schlembach PJ, Wilder RB, Jones D, Ha CS, Fayad LE, Younes A, Hagemeister F, Hess M, Cabanillas F, Cox JD. Schlembach PJ, et al. Cancer J. 2002 Sep-Oct;8(5):377-83. doi: 10.1097/00130404-200209000-00008. Cancer J. 2002. PMID: 12416895
Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
Chronowski GM, Wilder RB, Tucker SL, Ha CS, Younes A, Fayad L, Rodriguez MA, Hagemeister FB, Barista I, Cabanillas F, Cox JD. Chronowski GM, et al. Among authors: hagemeister fb. Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):36-43. doi: 10.1016/s0360-3016(02)03915-9. Int J Radiat Oncol Biol Phys. 2003. PMID: 12504034
Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes.
Dang NH, Hagemeister FB, Duvic M, Romaguera JE, Younes A, Jones D, Samuels B, Fayad LE, Pro B, Samaniego F, Sarris A, Goy A, McLaughlin P, Tong AT, Walker PL, Tiongson LP, Smith TL, Huh YO, Morimoto C, Rodriguez MA. Dang NH, et al. Among authors: hagemeister fb. Oncol Rep. 2003 Sep-Oct;10(5):1513-8. Oncol Rep. 2003. PMID: 12883733 Clinical Trial.
Second malignancies after chemotherapy and radiotherapy for Hodgkin disease.
Chronowski GM, Wilder RB, Levy LB, Atkinson EN, Ha CS, Hagemeister FB, Barista I, Rodriguez MA, Sarris AH, Hess MA, Cabanillas F, Cox JD. Chronowski GM, et al. Among authors: hagemeister fb. Am J Clin Oncol. 2004 Feb;27(1):73-80. doi: 10.1097/01.coc.0000045853.73233.42. Am J Clin Oncol. 2004. PMID: 14758137
Thalidomide for patients with recurrent lymphoma.
Pro B, Younes A, Albitar M, Dang NH, Samaniego F, Romaguera J, McLaughlin P, Hagemeister FB, Rodriguez MA, Clemons M, Cabanillas F. Pro B, et al. Among authors: hagemeister fb. Cancer. 2004 Mar 15;100(6):1186-9. doi: 10.1002/cncr.20070. Cancer. 2004. PMID: 15022285 Free article.
250 results